Assessing Human Alloimmunization as a Strategy for Inducing HIV Type 1 Neutralizing Anti-HLA Responses

AIDS Research and Human Retroviruses

Volumn 19, Issue 11, 2003, Pages 957-965

  Leith, Jonathan G ^a   Clark, David A ^b   Matthews, Thomas J ^c   Rosenthal, Kenneth L ^b   Luscher, Mark A ^d   Barber, Brian H ^a   Macdonald, Kelly S ^a,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Trimeris Inc   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; VACCINE;

ADOPTIVE IMMUNOTHERAPY; ALLELE; ALLOIMMUNIZATION; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HAPLOTYPE; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; IN VITRO STUDY; LEUKOCYTE; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPONTANEOUS ABORTION; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ABORTION, SPONTANEOUS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE SERA; IMMUNIZATION; IMMUNOGLOBULIN G; ISOANTIBODIES; LEUKOCYTES; MALE; NEUTRALIZATION TESTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0345688759     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203322588305     Document Type: Article

References (23)

1. Hoxie JA, Fitzharris TP, Youngbar PR, Matthews DM, Rackowski JL, and Radka SF: Nonrandom association of cellular antigens with HTLV-III virions. Hum Immunol 1987;18(1):39-52.
2. Castilletti C, Capobianchi MR, Fais S, Abbate I, Ficociello B, Ameglio F, Cordiali Fei P, Santini SM, and Dianzani F: HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. AIDS Res Hum Retroviruses 1995;11(5):547-553.
3. Azocar J and Essex M: Incorporation of HIA antigens into the envelope of RNA tumor viruses grown in human cells. Cancer Res 1979;39(9):3388-3391.
4. Arthur LO, Bess JW Jr, Sowder RC 2nd, Benveniste RE, Mann DL, Chermann JC, and Henderson LE: Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines [see comments]. Science 1992;258(5090):1935-1938.
5. Henderson LE, Sowder R, Copeland TD, Oroszlan S, Arthur LO, Robey WG, and Fischinger PJ: Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J Virol 1987;61:(2):629-632.
6. Tremblay M, Fortin J-F, and Cantin R: The acquisition of host-encoded proteins by nascent HIV-1. Immunol Today 1998;19: 346-351.
7. Stott EJ, Chan WL, Mills KH, Page M, Taffs F, Cranage M, Greenaway P, and Kitchin P: Preliminary report: Protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine [see comments]. Lancet 1990;336(8730): 1538-1541.
8. Stott EJ: Anti-cell antibody in macaques [letter] [see comments]. Nature 1991;353(6343):393.
9. Chan WL, Rodgers A, Grief C, Almond N, Ellis S, Flanagan B, Silvera P, Bootman J, Stott J, Kent K, et al.: Immunization with class I human histocompatibility leukocyte antigen can protect macaques against challenge infection with SIVmac-32H. AIDS 1995;9(3):223-228.
10. Arthur LO, Bess JW Jr, Urban RG, Stronringer JL, Morton WR, Mann DL, Henderson LE, and Benveniste RE: Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol 1995;69(5):3117-3124.
11. MacDonald KS, Embree J, Njenga S, Nagelkerke NJ, Ngatia I, Mohammed Z, Barber BH, Ndinya-Achola J, Bwayo J, and Plummer FA: Mother-child class 1 HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998;177(3):551-556.
12. Shearer GM, Clerici M, and Dalgleish A: Alloimmunization as an AIDS vaccine? Science 1993;262(5131):161-162.
13. Kiprov DD, Sheppard HW, and Hanson CV: Alloimmunization to prevent AIDS? Science 1994;263(5148):737-738.
14. Coulam CB, Clark DA, Beer AE, Kutteh WH, Silver R, Kwak J, and Stephenson M: Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Clinical Guidelines Recommendation Committee for Diagnosis and Treatment of Recurrent Spontaneous Abortion. Am J Reprod Immunol 1997;38(2):57-74.
15. Chackerian B, Long EM, Luciw PA, and Overbaugh J: Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol 1997;71(5):3932-3939.
16. Kimpton J and Emennan M: Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol 1992;66(4):2232-2239.
17. Sattentau QJ: Neutralization of HIV-1 by antibody. Curr Opin Immunol 1996;8(4):540-545.
18. Cantin R, Fortin JF, Lamontagne G, and Tremblay M: The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J Virol 1997;71(3):1922-1930.
19. Cantin R, Fortin JF, Lamontagne G, and Tremblay M: The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. Blood 1997;90(3):1091-1100.
20. Collins KL, Chen BK, Kalams SA, Walker BD, and Baltimore D: HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998;391(6665):397-401.
21. Dela Cruz CS, MacDonald KS, and Barber BH: Anti-major histocompatibility complex antibody responses in macaques via intradermal DNA immunizations. Vaccine 2000;18(27):3152-3165.
22. Gulukota K and DeLisi C: HLA allele selection for designing peptide vaccines. Genet Anal 1996;13(3):81-86.
23. Wang Y, Tao L, Mitchell E, Bravery C, Berlingieri P, Armstrong P, Vaughan R, Underwood J, and Lehner T: Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women. Nat Med 1999;5(9): 1004-1009.